136 related articles for article (PubMed ID: 17614266)
21. Intracameral moxifloxacin: in vitro safety on human ocular cells.
Kernt M; Neubauer AS; Liegl RG; Lackerbauer CA; Eibl KH; Alge CS; Ulbig MW; A AK
Cornea; 2009 Jun; 28(5):553-61. PubMed ID: 19421040
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and characterization of chitosan-based pH-sensitive semi-interpenetrating network microspheres for controlled release of diclofenac sodium.
Al-Kahtani Ahmed A; Bhojya Naik HS; Sherigara BS
Carbohydr Res; 2009 Mar; 344(5):699-706. PubMed ID: 19246032
[TBL] [Abstract][Full Text] [Related]
23. Chitosan-based spray-dried respirable powders for sustained delivery of terbutaline sulfate.
Learoyd TP; Burrows JL; French E; Seville PC
Eur J Pharm Biopharm; 2008 Feb; 68(2):224-34. PubMed ID: 17560772
[TBL] [Abstract][Full Text] [Related]
24. Facile preparation of magnetic 2-hydroxypropyltrimethyl ammonium chloride chitosan/Fe3O4/halloysite nanotubes microspheres for the controlled release of ofloxacin.
Wang Q; Zhang J; Mu B; Fan L; Wang A
Carbohydr Polym; 2014 Feb; 102():877-83. PubMed ID: 24507359
[TBL] [Abstract][Full Text] [Related]
25. Conjugation of squalene to acyclovir improves the affinity for biomembrane models.
Sarpietro MG; Micieli D; Rocco F; Ceruti M; Castelli F
Int J Pharm; 2009 Dec; 382(1-2):73-9. PubMed ID: 19686827
[TBL] [Abstract][Full Text] [Related]
26. Preparation and characterization of glutaraldehyde cross-linked O-carboxymethylchitosan microspheres for controlled delivery of pazufloxacin mesilate.
Liu YF; Huang KL; Peng DM; Ding P; Li GY
Int J Biol Macromol; 2007 Jun; 41(1):87-93. PubMed ID: 17292465
[TBL] [Abstract][Full Text] [Related]
27. Optimization of chitosan succinate and chitosan phthalate microspheres for oral delivery of insulin using response surface methodology.
Ubaidulla U; Khar RK; Ahmad FJ; Tripathi P
Pharm Dev Technol; 2009; 14(1):96-105. PubMed ID: 18821127
[TBL] [Abstract][Full Text] [Related]
28. Effect of formulation factors on in vitro permeation of moxifloxacin from aqueous drops through excised goat, sheep, and buffalo corneas.
Pawar PK; Majumdar DK
AAPS PharmSciTech; 2006 Feb; 7(1):E13. PubMed ID: 16584143
[TBL] [Abstract][Full Text] [Related]
29. Microspheres containing lipid/chitosan nanoparticles complexes for pulmonary delivery of therapeutic proteins.
Grenha A; Remuñán-López C; Carvalho EL; Seijo B
Eur J Pharm Biopharm; 2008 May; 69(1):83-93. PubMed ID: 18166446
[TBL] [Abstract][Full Text] [Related]
30. Chitosan microspheres prepared by spray drying.
He P; Davis SS; Illum L
Int J Pharm; 1999 Sep; 187(1):53-65. PubMed ID: 10502613
[TBL] [Abstract][Full Text] [Related]
31. In vitro study of the immune stimulating activity of an atrophic [correction of athrophic] rhinitis vaccine associated to chitosan microspheres.
Jiang HL; Park IK; Shin NR; Kang SG; Yoo HS; Kim SI; Suh SB; Akaike T; Cho CS
Eur J Pharm Biopharm; 2004 Nov; 58(3):471-6. PubMed ID: 15451520
[TBL] [Abstract][Full Text] [Related]
32. Comparative elution of moxifloxacin from Norian skeletal repair system and acrylic bone cement: an in vitro study.
Kanellakopoulou K; Tsaganos T; Athanassiou K; Koutoukas P; Raftogiannis M; Skiadas I; Giamarellou H
Int J Antimicrob Agents; 2006 Sep; 28(3):217-20. PubMed ID: 16904297
[TBL] [Abstract][Full Text] [Related]
33. Chitosan nanoparticles are compatible with respiratory epithelial cells in vitro.
Grenha A; Grainger CI; Dailey LA; Seijo B; Martin GP; Remuñán-López C; Forbes B
Eur J Pharm Sci; 2007 Jun; 31(2):73-84. PubMed ID: 17408932
[TBL] [Abstract][Full Text] [Related]
34. Chitosan microspheres as candidate plasmid vaccine carrier for oral immunisation of Japanese flounder (Paralichthys olivaceus).
Tian J; Yu J; Sun X
Vet Immunol Immunopathol; 2008 Dec; 126(3-4):220-9. PubMed ID: 18722672
[TBL] [Abstract][Full Text] [Related]
35. Genipin crosslinked ethyl cellulose-chitosan complex microspheres for anti-tuberculosis delivery.
Feng H; Zhang L; Zhu C
Colloids Surf B Biointerfaces; 2013 Mar; 103():530-7. PubMed ID: 23266829
[TBL] [Abstract][Full Text] [Related]
36. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
[TBL] [Abstract][Full Text] [Related]
37. Preparation of ionic-crosslinked chitosan-based gel beads and effect of reaction conditions on drug release behaviors.
Chen S; Liu M; Jin S; Wang B
Int J Pharm; 2008 Feb; 349(1-2):180-7. PubMed ID: 17900834
[TBL] [Abstract][Full Text] [Related]
38. Enhancement of dissolution rate and bioavailability of aceclofenac: a chitosan-based solvent change approach.
Mutalik S; Anju P; Manoj K; Usha AN
Int J Pharm; 2008 Feb; 350(1-2):279-90. PubMed ID: 17945447
[TBL] [Abstract][Full Text] [Related]
39. Preparation and release of salbutamol from chitosan and chitosan co-spray dried compacts and multiparticulates.
Corrigan DO; Healy AM; Corrigan OI
Eur J Pharm Biopharm; 2006 Apr; 62(3):295-305. PubMed ID: 16314079
[TBL] [Abstract][Full Text] [Related]
40. In vitro release and characterization of chitosan films as dexamethasone carrier.
Rodrigues LB; Leite HF; Yoshida MI; Saliba JB; Cunha AS; Faraco AA
Int J Pharm; 2009 Feb; 368(1-2):1-6. PubMed ID: 18955123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
